Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-olds

2 Mar 2021

Abstract excerpt

BACKGROUND: Increased knowledge of the evolution of molecular changes in neurodegenerative disorders such as Alzheimer's disease (AD) is important for the understanding of disease pathophysiology and also crucial to be able to identify and validate disease biomarkers. While several biological changes that occur early in the disease development have already been recognized, the need for further characterization of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Cerebrospinal fluid and hydrocephalus
Share to Dementia and Cognitive Impairment Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33653397
DOI: 10.1186/s13195-021-00789-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-oldsPMID 33653397Read ↗

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular eventsSemantic proximity Read ↗

Emerging Biomarkers for Early Detection of Alzheimer’s Disease: A Systematic ReviewSemantic proximity Read ↗

The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease.Semantic proximity Read ↗

Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s diseaseSemantic proximity Read ↗

Amyloid-beta and tau proteins as biochemical markers of Alzheimer's diseaseSemantic proximity Read ↗

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”Semantic proximity Read ↗

Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer’s disease: A literature reviewSemantic proximity Read ↗

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease.Semantic proximity Read ↗

Cerebrospinal Fluid Biomarkers in Familial Forms of Alzheimer's Disease and Frontotemporal Dementia.Semantic proximity Read ↗

The Use of Proteomics in Biomarker Discovery in Neurodegenerative DiseasesSemantic proximity Read ↗

Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer’s diseaseSemantic proximity Read ↗

Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.